Trevena
TRVN
#10609
Rank
S$0.01 M
Marketcap
S$0.01555
Share price
0.00%
Change (1 day)
-99.29%
Change (1 year)

Trevena (TRVN) - Total assets

Total assets on the balance sheet as of September 2024 : S$24.86 Million

According to Trevena's latest financial reports the company's total assets are S$24.86 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Trevena - Total assets on balance sheet (from 2012 to 2024)

Total assets by year

Year Total assets Change
2023-12-31S$53.62 M-17.83%
2022-12-31S$65.26 M-39.75%
2021-12-31S$0.10 B-35.9%
2020-12-31S$0.16 B166.73%
2019-12-31S$63.35 M-30.55%
2018-12-31S$91.23 M-6.21%
2017-12-31S$97.26 M-41.38%
2016-12-31S$0.16 B-33.1%
2015-12-31S$0.24 B73.43%
2014-12-31S$0.14 B166.28%
2013-12-31S$53.71 M443.06%
2012-12-31S$9.89 M-60.65%
2011-12-31S$25.13 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Amgen
AMGN
S$116.81 B 469,677.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
S$1.86 B 7,386.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
S$56.79 M 128.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$167.87 B 675,040.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
S$26.42 M 6.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA